Astaxanthin | Antioxidant

Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	472-61-7
Formula :	C₄₀H₅₂O₄
M.W :	596.84
SMILES Code :	CC(/C=C/C(C(C)(C)C[C@@H]1O)=C(C)C1=O)=C\C=C\C(C)=C\C=C\C=C(C)\C=C\C=C(C)\C=C\C(C(C)(C)C[C@@H]2O)=C(C)C2=O
MDL No. :	MFCD00672621
InChI Key :	MQZIGYBFDRPAKN-UWFIBFSHSA-N
Pubchem ID :	5281224

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H319-H335
Precautionary Statements:	P261-P305+P351+P338

GL261 cells	10 µM	72 h	reduced the number of BrdU-positive cells	PMC7551886
U251MG cells	10 µM	48 h	suppressed cell migration by 21.15 ± 1.84%	PMC7551886
Lymphocytes	70-300 nM	48 h	To evaluate the effect of astaxanthin on lymphocyte proliferation, results showed that astaxanthin at 300 nM significantly promoted splenic lymphocyte proliferation.	PMC4730289
SK-N-SH cells	0, 50, 100, 200, 400 µM	72 h	Astaxanthin significantly inhibited the proliferation of SK-N-SH cells in a concentration-dependent manner.	PMC10685499
SK-N-SH cells	200 µM	24 h	Astaxanthin suppressed the clone formation ability of SK-N-SH cells, and the effect was highest when combined with si-STAT3.	PMC10685499
SK-N-SH cells	200 µM	24 h	Astaxanthin induced apoptosis in SK-N-SH cells, and the apoptosis rate was highest when combined with si-STAT3.	PMC10685499
SK-N-SH cells	200 µM	16 h	Astaxanthin suppressed the migration and invasion of SK-N-SH cells, and the effect was best when combined with si-STAT3.	PMC10685499
Bone marrow-derived macrophages (BMMs)	30 µM	4 days	Astaxanthin inhibited RANKL and M-CSF-induced osteoclast differentiation by suppressing the expression of NFATc1, TRAP, DC-STAMP, and cathepsin K, without cytotoxic effects on BMMs.	PMC5877773
Huh7 cells	1-20 µM	24 h	To evaluate the effect of astaxanthin on cell viability, results showed that astaxanthin did not exhibit any significant cytotoxicity in concentrations of up to 20 µM in Huh7 cells	PMC4730345
PON1-Huh7 cells	1-20 µM	48 h	To evaluate the effect of astaxanthin on PON1 enzyme activity, results showed that astaxanthin significantly induced PON1 enzyme activity	PMC4730345
HepG2 cells	1-20 µM	24 h	To evaluate the effect of astaxanthin on glutathione levels, results showed that astaxanthin dose-dependently increased cellular glutathione levels	PMC4730345

Mice	Aged mice	Oral	300 mg/kg	Once daily for 8 weeks	To evaluate the effects of astaxanthin on muscle strength and muscle quality in aged mice. Results showed that the specific force was significantly higher in the astaxanthin-treated group compared to the placebo group.	PMC6204600
mice	glioblastoma model	oral	10 and 30 mg/kg	daily for 10 days	suppressed the glioblastoma progression	PMC7551886
C57BL/6 mice	OVA-induced asthma model	Oral	5, 10, 50 mg/kg	Once daily for 5 days	To investigate the inhibitory effect of astaxanthin on airway inflammation in OVA-induced asthmatic mice. Results showed that astaxanthin significantly inhibited respiratory system resistance, elastance, newtonian resistance, tissue damping, and tissue elastance. It also suppressed the total cell number, IL-4, and IL-5, and increased IFN-γ in BALF. In sera, total IgE, IgG1, and OVA-specific IgG1 levels were reduced, while IgG2a and OVA-specific IgG2a levels were increased.	PMC6150233
Mice	Not specified	Oral	0.28, 1.4 and 7 mg/kg	Once daily for 14 days	To evaluate the effect of astaxanthin on lymphocyte proliferation in mice, results showed that astaxanthin significantly enhanced LPS-induced lymphocyte proliferation.	PMC4730289
Mice	Phf7 knockout mice	Oral	30 mg/kg	Once daily for 4 weeks	To investigate the therapeutic effect of astaxanthin on spermatogenesis defects in Phf7 knockout mice, results showed that astaxanthin significantly increased sperm count and motility, and reduced ROS levels and germ cell apoptosis in the testis	PMC10618686
Nude mice	SK-N-SH tumor model	Intragastric administration	200 mg/kg	Once daily for 4 weeks	Astaxanthin suppressed the growth of SK-N-SH tumors in nude mice, and the effect was highest when combined with si-STAT3.	PMC10685499
C3H/HeN female mice	Ovariectomy-induced osteoporosis model	Oral	5 mg/kg and 10 mg/kg	Once daily for 6 weeks	Oral administration of AST for 6 weeks inhibited the increase in and uterine atrophy in ovariectomized mice, reduced serum levels of calcium, inorganic phosphorus, alkaline phosphatase, and total cholesterol, and suppressed TRAP activity. Additionally, AST improved the bone microarchitecture of the tibia and femur, increased trabecular bone volume and number, and decreased trabecular separation. AST also inhibited the reduction of bone mineral density in the femur and tibia and reduced the number of TRAP-positive cells.	PMC5877773
mice	LPS-induced sepsis model	oral	50, 100, and 200 mg/kg	every 24 hours for 2 days	To evaluate the antioxidant ability of Astaxanthin in LPS-induced mice sepsis model, the results showed that Astaxanthin significantly suppressed NO and ROS production and reduced lipid peroxidation activities.	PMC8540215

{[proInfo.proName]}

CAS No.: 472-61-7

{[proInfo.proName]}

CAS No.: 472-61-7

Alternative Products

Product Details of Astaxanthin

Safety of Astaxanthin

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

NCT02264938	Macular Degeneration	Not Applicable	Completed	-	-
NCT03702374	Diabetic Retinopathy	Phase 3	Recruiting	November 1, 2020	Mexico ... More >> Institute of Experimental and Clinical Therapeutics, Recruiting Guadalajara, Jalisco, Mexico, 44340 Contact: Adolfo D. Rodriguez-Carrizalez, PhD +52 33 10585200 ext 33658 adolfo.rodriguez@academicos.udg.mx Contact: Cecilia Olvera-Montaño, MD +52 33 10 58 52 00 ext 33658 ceciliaom.drcrt@gmail.com Sub-Investigator: Cecilia Olvera-Montaño, MD Sub-Investigator: José A. Castellanos-González, MSc Sub-Investigator: Alejandra G Miranda-Díaz, PhD Less <<
NCT02582424	Hyperlipidemia	Not Applicable	Completed	-	-
NCT01323036	Healthy Volunteers	Not Applicable	Completed	-	Canada, Manitoba ... More >> Richardson Centre for Functional Foods and Nutraceuticals Winnipeg, Manitoba, Canada, R3T 2N2 Less <<
NCT02422927	Atherosclerosis ... More >> Inflammation Hypercholesterolemia Less <<	Phase 4	Completed	-	-
NCT02969070	Hypercholesterolemia ... More >> Endothelial Dysfunction Less <<	Phase 3	Unknown	March 2017	Italy ... More >> University of Naples "Federico II" Recruiting Naples, Italy, 80131 Contact: Giuseppe Giugliano, MD, PhD +390817462240 giuseppe.giugliano@unina.it Sub-Investigator: Raffaele Izzo, MD Sub-Investigator: Maurizio Galderisi, MD Sub-Investigator: Giuseppe Giugliano, MD, PhD Less <<
NCT01562080	Hyperlipidemia ... More >> Low-density-lipoprotein-type Elevated Triglycerides Less <<	Phase 2 Phase 3	Completed	-	Spain ... More >> Hosp. Universitario San Joan Reus, Tarragona, Spain Less <<
NCT02062034	Non-proliferative Diabetic Ret... More >>inopathy Diabetes Mellitus Type 2 Less <<	Phase 2	Completed	-	Mexico ... More >> Cardiovascular Research Unit, University of Guadalajara Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT03216811	Hypercholesterolemia	Phase 2	Completed	-	Italy ... More >> University Hospital of Ferrara Cona, Ferrara, Italy, 44124 Less <<
NCT03470376	Hypercholesterolemia ... More >> Inflammation Atherosclerosis Less <<	Phase 4	Completed	-	-
NCT01087632	Metabolic Syndrome	Not Applicable	Completed	-	Italy ... More >> Federico II University - Department of Internal Medicine Naples, Italy Less <<
NCT01647984	Ventricular and Atrial Extrasy... More >>toles Less <<	Phase 4	Completed	-	Italy ... More >> Ambulatorio Ipertensione e Unità Coronarica Federico II University Naples, Italy, 80131 Less <<
NCT02087033	Arrhythmia	Not Applicable	Unknown	-	Italy ... More >> Policlinico San Pietro Recruiting Ponte San Pietro, Bergamo, Italy, 24100 Contact: flavio doni, MD 0039035604416 flavio.doni@fastwebnet.it Sub-Investigator: flavio doni, MD Policlinico San Donato Recruiting San Donato Milanese, Milan, Italy, 20097 Contact: riccardo cappato, MD 0252774337 riccardo.cappato@grupposandonato.it Sub-Investigator: Cristina Balla, MD Less <<
NCT01167205	Healthy Overw... More >>eight Obesity Less <<	Not Applicable	Unknown	-	Korea, Republic of ... More >> Clinical Research Institute Seoul National University Hospital Not yet recruiting Seoul, Korea, Republic of, 110-744 Contact: Wan Gyoon Shin, Ph D, Pharm D +82 2 740 85556 wgshin@snu.ac.kr Less <<
NCT01241877	Athletic Performance	Not Applicable	Unknown	-	Netherlands ... More >> Maastricht University Recruiting Maastricht, LI, Netherlands, 6229 Contact: Peter Res, MSc +3143381383 peter.res@maastrichtuniversity.nl Less <<
NCT03460860	Skin Aging Wr... More >>inkles Less <<	Not Applicable	Recruiting	September 7, 2018	Philippines ... More >> PDC Building, 1440 Taft Avenue Recruiting Manila, Metro Manila, Philippines Contact: Nenita Alberto, MD (632) 5232519 albertonenita@yahoo.com Less <<
NCT02343497	Dyslipidemias	Not Applicable	Completed	-	France ... More >> Centre Nutrition Clinique Naturalpha Lille, France, 59020 Less <<
NCT03443882	Healthy Volunteers	Early Phase 1	Active, not recruiting	September 25, 2018	Israel ... More >> Bert W. Strassburger Lipid Center, Sheba Medical Center, Tel Hashomer, Israel, 52621 Less <<
NCT02373111	Ageing Photo-... More >>aging Less <<	Not Applicable	Completed	-	Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110744 Less <<
NCT02310087	Infertility, Male	Not Applicable	Recruiting	December 2019	Slovenia ... More >> Division of Ob/Gyn, University Medical Centre Ljubljana Recruiting Ljubljana, Slovenia, 1000 Contact: Bojana Pinter, MD, PhD +386-41-718-923 bojana.pinter@kclj.si Contact: Senka Imamovic Kumalic, MD +386-40-614-904 senka81@gmail.com Less <<
NCT03368872	Sarcopenia	Not Applicable	Completed	-	United States, Washington ... More >> Fred Hutchinson Cancer Research Center Prevention Center Seattle, Washington, United States, 98109 University of Washington Medical Center Seattle, Washington, United States, 98195 Less <<
NCT03209895	Joint Pain	Not Applicable	Completed	-	United States, California ... More >> 1621 Bridgeway Sausalito, California, United States, 94965 Less <<
NCT02088242	Body Temperature Regulation	Not Applicable	Unknown	August 2015	Israel ... More >> Sheba medical center Not yet recruiting Tel-Hashomer, Ramat- Gan, Israel Contact: Ofir Frenkel, M.D +972529243399 Ofir.Frenkel@sheba.health.gov.il Principal Investigator: Ofir Frenkel, M.D Less <<
NCT03310359	Metabolic Syndrome X	Phase 1	Recruiting	April 2018	United States, California ... More >> Altman Clinical and Translational Research Institute (ACTRI) Recruiting San Diego, California, United States, 92037 Contact: Adrienne Armstrong, BA 858-646-2884 a3armstrong@ucsd.edu Sub-Investigator: Sunder Mudaliar, MD Sub-Investigator: Jeremy Pettus, MD Less <<
NCT03664466	Osteoarthritis, Knee	Not Applicable	Not yet recruiting	December 2019	-
NCT02397811	Bioavailability of Astaxanthin... More >> Formulations Less <<	Not Applicable	Completed	-	United States, Florida ... More >> USF Health: College of Medicine Tampa, Florida, United States, 33612 Less <<

Bio Calculators
Preparing Stock Solutions		1mg	5mg	10mg
Preparing Stock Solutions	1 mM 5 mM 10 mM	1.68mL 0.34mL 0.17mL	8.38mL 1.68mL 0.84mL	16.75mL 3.35mL 1.68mL
Dissolving Methods	Animal experiment The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed